Skip to search formSkip to main contentSkip to account menu

Benemid

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1977
1977
A noninvasive method for measurement of the individual kidney filtration fraction (FF) is presented, based on an analysis of the… 
1975
1975
  • S. VermaE. Kieff
  • 1975
  • Corpus ID: 43261532
Hematuria and eosinophilia developed in two patients being treated for bacterial endocarditis with 20 or 24 gm/day of cephalexin… 
1957
1957
Pseudohypoparathyroidism, a disease first described by Albright and co-workers, 1 differs from true hypoparathyroidism in… 
1956
1956
PROBENECID (Benemid)* has been established as an outstanding uricosuric agent of value in the treatment of chronic gout.† The… 
Review
1955
Review
1955
RECOGNITION and treatment of reversible disease is the primary function of the physician. This is particularly true when… 
1955
1955
Summary The renal clearance of erythromycin is slightly less than the glomerular filtration rate in dogs. Benemid appears to… 
1953
1953
Summary 1. At plasma levels of 30 to 50 μg/cc, significant renal tubular secretion of pantothenic acid occurs. 2. It is probable… 
1953
1953
1) P-(di-n-propylsulfamyl)-benzoic acid (“Benemid”—Sharp & Dohme) was administered orally to 10 patients in conjunction with… 
1951
1951
Summary and Conclusions (1) The data presented demonstrate that Benemid in doses of 2 g per day per adult produced approximately…